|
[1]CHEN W, ZHENG R, BAADE PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66 (2) :115-132.
|
|
[2]ARENDS JW.Molecular interactions in the vogelstein model of colorectal carcinoma[J].J Pathol, 2000, 190 (4) :412-416.
|
|
[3]MOURI H, SAKAGUCHI K, SAWAYAMA T, et al.Suppressive effects of transforming growth factor-beta1 produced by hepatocellular od mononuclear cells[J].Acta Med Okayama, 2002, 56 (6) :309-315.
|
|
[4]SHIRAI Y, KAWATA S, ITO N, et al.Elevated levels of plasma transforming growth factor-beta in patients with hepatocellula carcinoma cell lines on interferon-gamma production by peripheral blor carcinoma[J].Jpn J Cancer Res, 1992, 83 (7) :676.
|
|
[5]SHIRAI Y, KAWATA S, TAMURA S, et al.Plasma transforming growth factor-β1 in patients with hepatocellul arcarcinoma.Comparison with chronic liver disease[J].Cancer, 1994, 73:2275.
|
|
[6]SACCO R, LEUCI D, TORTORELLA C, et al.Transforming growth factor-β1 and soluble Fas serum levels in hepatocellular carcinoma[J].Cytokine, 2000, 12 (6) :811-814.
|
|
[7]FENG JH, LIU ZQ, WEI YY, et al.Diagnosis value of the joint test of serum GPC3 and TGFβ1 in AFP negative primary liver cancer patients[J].Int J Lab Med, 2015, 36 (19) :2787-2788. (in Chinese) 冯军花, 刘志权, 魏媛媛, 等.血清GPC3与TGFβ1联合检测对AFP阴性原发性肝癌的诊断价值[J].国际检验医学杂志, 2015, 36 (19) :2787-2788.
|
|
[8]GAN XT, BAI XG, HUANG TX, et al.Clinical significance of transforming growth factor-β1 in urine of patients with primary hepatic carcinoma[J].Med J Chin People's Armed Police Forces, 2003, 14 (9) :535-538. (in Chinese) 甘雪婷, 白宪光, 黄团新, 等.尿转化生长因子β1在原发性肝癌中的检测及临床意义[J].武警医学, 2003, 14 (9) :535-538.
|
|
[9]QIU LW, YAO DF, HUANG F, et al.Expression levels of TGFβ1, TNF-alpha and MMP-13 and their clinical values in patients with chronic liver diseases[J].J Nantong Univ:Med Sci, 2005, 25 (4) 244-246, 249. (in Chinese) 邱历伟, 姚登福, 黄峰, 等.慢性肝病患者转化生长因子-β1、肿瘤坏死因子-α和基质金属蛋白酶-13表达与临床价值[J].南通大学学报:医学版, 2005, 25 (4) :244-246, 249.
|
|
[10]SHAO Y, WANG ZR, LI F.The diagnostic value of transforming growth factor-β1 and alpha-fetoprotein L3 combined examination in hepatocellular carcinoma[J].J Mod Oncol, 2010, 18 (10) :2009-2012. (in Chinese) 邵渊, 王作仁, 李峰.转化生长因子-β1联合甲胎蛋白异质体二联检测对原发性肝癌诊断的意义[J].现代肿瘤医学, 2010, 18 (10) :2009-2012.
|
|
[11]XIAO WL, HA S, REN ZH, et al.Clinical value of combined detection of GP73, AFP-L3 and TGFβ1 in early diagnosis of hepatocellular carcinoma[J].Int J Lab Med, 2014, 35 (14) :1839-1841. (in Chinese) 肖伟利, 哈斯, 任志宏, 等.GP73、AFP-L3和TGFβ1联合检测在肝细胞癌早期诊断中的临床价值[J].国际检验医学杂志, 2014, 35 (14) :1839-1841.
|
|
[12]ZHANG CC, CHU RH, HAN P, et al.Diagnosis value analysis of serum AFP, GPC3, TGFβ1 single and combined testing on primary liver cancer[J].Qingdao Med J, 2012, 44 (2) :108-110. (in Chinese) 张彩彩, 褚瑞海, 韩鹏, 等.血清AFP、GPC3、TGFβ1单独及联合检测对原发性肝癌的诊断价值分析[J].青岛医药卫生, 2012, 44 (2) :108-110.
|
|
[13]TAI BJ, YAO DF, QIU LW, et al.Diagnostic value of circulating transforming growth factor-β1 and free insulin-like growth factor-II abnormalities for hepatocellular carcino ma[J].Clin Focus, 2007, 22 (24) :1757-1760. (in Chinese) 邰伯军, 姚登福, 邱历伟, 等.外周血转化生长因子β1和游离胰岛素样生长因子II异常与肝癌诊断[J].临床荟萃, 2007, 22 (24) :1757-1760.
|
|
[14]WU ZL, YAO DF, DONG ZZ, et al.Dignostic and differential diagnostic values of plasm-a transforming growth factor-β1 in patients with primary liver cancer[J].Chin J Gastroenterol Hepatol, 2004, 13 (5) :502-504. (in Chinese) 吴志兰, 姚登福, 董志珍, 等.转化生长因子-β1对原发性肝癌诊断与鉴别的临床价值[J].胃肠病学和肝病学杂志, 2004, 13 (5) :502-504.
|
|
[15]ZHANG D, LI Y, XU ZQ, et al.Clinical value of tumor marker in peripheral blood to the diagnosis of hepatocellular carcinoma[J].JChin Practical Diagn Ther, 2011, 25 (8) :742-744. (in Chinese) 张丹, 李远, 徐泽强, 等.外周血肝癌标志物在肝癌诊断中的价值[J].中华实用诊断与治疗杂志, 2011, 25 (8) :742-744.
|
|
[16]TSAI JF, JENG JE, CHUANG LY, et al.Elevated urinary transforming growth factor-beta1 level as a tumour marker and predictor of poor survival in cirrhotic hepatocellular carcinoma[J].Br J Cancer, 1997, 76 (2) :244-250.
|
|
[17]El-BASSIOUNY AE, ZOHEIRY MM, NOSSEIR MM, et al.Expression of cyclooxygenase-2 and transforming growth factor-beta1in HCV-induced chronic liver disease and hepatocellular carcinoma[J].Med Gen Med, 2007, 9 (3) :45.
|
|
[18]HE FY, ZHENG YL, WANG Y, et al.Clinical significance of TGF-β1 and PCNA expression in primary human hepatocarcinoma tissues[J].World Chin J Dig, 1998, 6 (7) :165-166. (in Chinese) 何凤云, 郑英兰, 王颖, 等.原发性肝癌组织TGFβ1和PCND的表达和意义[J].世界华人消化杂志, 1998, 6 (7) :165-166.
|
|
[19]KANG KF, SHI XC, CHEN XW, et al.Expression of PTTG and TGFβ1 with its receptor in hepatocellular carcinoma and their clinical significant[J].Chin J Cancer Prev Treat, 2007, 14 (6) :1223-1225. (in Chinese) 康凯夫, 石祥呈, 陈小伍, 等.肝癌组织中PTTG与TGFβ1及受体的表达及其临床意义[J].中华肿瘤防治杂志, 2007, 14 (6) :1223-1225.
|
|
[20]SHEN GD, JIANG RQ, SUN BC.Expressions of inflammation-associated factors IL-1β, TGF-βand MCP-1 in human hepatocellular carcinoma[J].Jiangsu Med J, 2011, 37 (7) :797-799. (in Chinese) 沈国定, 姜润秋, 孙倍成.炎症相关因子IL-1β, TGF-β及MCP-1在肝细胞肝癌的表达[J].江苏医药, 2011, 37 (7) :797-799.
|
|
[21]ZHAO W, LI ZY.The expression of Runx3、TGFβ1、β-catenin and Cyclin D1 in primary liver cancer and their correlation studies[D].Yinchuan:Ningxia Med Univ, 2012. (in Chinese) 赵伟, 李昭宇.Runx3、TGFβ1、β-catenin及Cyclin D1在原发性肝癌中的表达及相关性研究[D].银川:宁夏医科大学, 2012.
|
|
[22] ARENDS JW.Molecular interactions in the vogelstein model of colorectal carcinoma[J].J Pathol, 2000, 190 (4) :412-416.
|
|
[23]KIM KY, JEONG SY, WON J, et al.Induction of angiogenesis byexpression of soluble type II transforming growth factorbeta receptorinmouse hepatoma[J].J Biol Chem, 2001, 276 (42) :38781-38786.
|
|
[24]TAI BJ, YAO DF, ZOU L, et al.Dynamic expressions of transforming growth factor-β1 and tumor necrosis factor-αin hepatic oncogenesis[J].Chin J Gastroenterol Hepatol, 2006, 15 (3) :277-280. (in Chinese) 邰伯军, 姚登福, 邹黎, 等.肝细胞癌变过程中TGF-β1及TNFα的动态表达与改变[J].胃肠病学和肝病学杂志, 2006, 15 (3) :277-280.
|
|
[25]WANG Y, LIU T, TANG W, et al.Hepatocellular carcinoma cells induce regulatory T cells and lead to poor prognosis via production of transforming growth factor-β1[J].Cell Physiol Biochem, 2016, 38 (1) :306-318.
|
DownLoad: